Kusajili – Clinical trials directory

Result of your search per sponsor: National Institute of Public Health and Environment (RIVM, the Netherlands)

Woman and Man Max 99 years
National Institute of Public Health and Environment (RIVM, the Netherlands) Update Il y a 4 ans

Study to determine the appropriate age for a second immunization with the Meningococcal C conjugated vaccine - To assess serum MenC-PS specific IgG levels at T0 (prior to vaccination) and at 1 month (T1) and 1 year (T2) after the second MenCC vaccination and determine whether there is a difference in IgG lev...

Country None
organs None
Specialty None

unknown

More information

Woman and Man Max 99 years
National Institute of Public Health and Environment (RIVM, the Netherlands) Update Il y a 4 ans

Second meningococcal vaccination in Dutch children: Study to compare the tetravalent MenACWY-TT conjugate vaccine with the monovalent MenC-TT conjugate vaccine. Tweede meningokokken vaccinatie bij nederlandse kinderen: Een onderzoek waarbij het tetravelente MenACWY-TT vaccin vergeleken zal worden met het monovalente MenC-TT vaccin The primary objective is to demonstrate non-inferiority of SBA levels against MenC at 1 year (T2) after vaccination in the group vaccinated with tetravalent MenACWY-TT vaccine as compared with the gro...

Country None
organs None
Specialty None

unknown

More information